The "Protein Expression Market- Growth, Trends, and Forecast (2019 - 2024)" report has been added to ResearchAndMarkets.com's offering.
The propelling factors for the growth of the protein expression market includes the rise in the R&D activity in the pharmaceutical sector, opportunities in the field of proteomics, advancements in the biologics market set to boost the market growth, and increasing incidences of chronic diseases.
Biologics have played a crucial role in the treatment process of many health issues. The success of Humira, a drug for the treatment of rheumatoid arthritis, has been an encouraging factor for many drug makers to continue working in the pathway of biologics. Therefore, it is expected that the biologics industry may grow exponentially in the future. This is attributed to the fact that biologics is counted upon to deliver cures through gene therapy using viruses. Therefore, similar technological advances are thus expected to boost the growth of the biologics market.
In addition the biotechnology-based organizations have also created a big opportunity for the protein expression market growth by developing novel therapeutics with minimal side effects. The increasing research intensity in the pharmaceutical sector is adding up to the opportunities for growth.
Therefore at present, the protein expression market is a highly attractive and profitable market due to the increasing adoption of biotechnology as well as genetic engineering in the pharmaceutical industry and medical science.
Key Market Trends
Cell Free Expression is the Largest Segment Under Expression System that is Expected to Grow During the Forecast Period
The cell-free protein expression is well-established in the market, due to the acceptance of it and this protein expression is performed without the use of living cells. This technique has many advantages over other protein expression techniques and because of its advantages, it is widely used. Due to the advantages of cell-free protein techniques, such as increased speed, ability to express toxic proteins, ease of amino acid type selective labeling, among others, these are making the cell expression market to grow.
Therefore, the unique technology may increase the growth of the cell-free expression market, which in turn, is expected to boost the protein expression market.
North America is the Largest Growing Market that is Expected to Continue the Same Trend Over the Forecast Period
North America is the largest market for protein expression and is expected to dominate the overall protein expression market due to factors like the presence of well-established healthcare infrastructure in these regions combined with the intense R&D activities carried out. The United States protein expression market is driven by factors, such as an increase in the usage of protein technologies, the rapid evolution of the pharmaceutical industry in the region, and the presence of several companies in the region itself.
The companies present have a broad product portfolio with comprehensive features and have a strong geographical presence. Furthermore, these leaders cater to the requirements of major end users, such as research laboratories and pharmaceutical and biotechnology companies.
Key Topics Covered
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Rise in the R&D Activity in the Pharma Sector
4.2.2 Opportunities in the Field of Proteomics
4.2.3 Advancements in the Biologics Market set to Boost the Market Growth
4.2.4 Increasing Incidences of Chronic Diseases
4.3 Market Restraints
4.3.1 High Cost of Protein Expression Reagents and Instruments
4.3.2 Increasing Consolidation and High Barriers for New Entrants
4.4 Porter's Five Forces Analysis
5 MARKET SEGMENTATION
5.1 By Expression System
5.1.1 Cell-Free Expression
5.1.2 Bacterial Expression
5.1.3 Yeast Expression
5.1.4 Algal Expression
5.1.5 Insect Expression
5.1.6 Mammalian Expression
5.1.7 Other Expression Systems
5.2 By Product
5.2.4 Other Products
5.3 By End User
5.3.3 Other End Users
5.4.1 North America
5.4.4 Middle East & Africa
5.4.5 South America
6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Agilent Technologies Inc.
6.1.2 Bio-Rad Technologies
6.1.3 EMD Millipore
6.1.4 Takara Bio Inc.
6.1.5 New England Biolabs Inc.
6.1.6 Oxford Expression Technologies Ltd.
6.1.7 Promega Corporation
6.1.8 Qiagen N.V.
6.1.9 Sigma-Aldrich Corporation
6.1.10 Thermo Fisher Scientific Inc.
7 MARKET OPPORTUNITIES AND FUTURE TRENDS
For more information about this report visit https://www.researchandmarkets.com/r/mz4cc1
These press releases may also interest you